UA73072C2 - Plasmids of bacteria - Google Patents
Plasmids of bacteria Download PDFInfo
- Publication number
- UA73072C2 UA73072C2 UA99105881A UA99105881A UA73072C2 UA 73072 C2 UA73072 C2 UA 73072C2 UA 99105881 A UA99105881 A UA 99105881A UA 99105881 A UA99105881 A UA 99105881A UA 73072 C2 UA73072 C2 UA 73072C2
- Authority
- UA
- Ukraine
- Prior art keywords
- life
- plasmids
- dna
- plasmid
- dna molecule
- Prior art date
Links
- 239000013612 plasmid Substances 0.000 title claims abstract description 66
- 241000894006 Bacteria Species 0.000 title description 8
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 15
- 239000013604 expression vector Substances 0.000 claims abstract description 7
- 108020004414 DNA Proteins 0.000 claims description 24
- 239000002773 nucleotide Substances 0.000 claims description 4
- 125000003729 nucleotide group Chemical group 0.000 claims description 4
- 102000053602 DNA Human genes 0.000 claims 6
- 230000002906 microbiologic effect Effects 0.000 claims 4
- 230000001900 immune effect Effects 0.000 claims 1
- 238000012876 topography Methods 0.000 claims 1
- 241000305071 Enterobacterales Species 0.000 abstract description 10
- 241000588724 Escherichia coli Species 0.000 abstract description 2
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 235000010469 Glycine max Nutrition 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000011521 glass Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000001018 virulence Effects 0.000 description 4
- 244000068988 Glycine max Species 0.000 description 3
- 125000003275 alpha amino acid group Chemical group 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000003306 harvesting Methods 0.000 description 3
- 230000007918 pathogenicity Effects 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000000304 virulence factor Substances 0.000 description 3
- 230000007923 virulence factor Effects 0.000 description 3
- 235000014101 wine Nutrition 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000013611 chromosomal DNA Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 125000004354 sulfur functional group Chemical group 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- 241000283153 Cetacea Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 108700038720 Ebip Proteins 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 101000844521 Homo sapiens Transient receptor potential cation channel subfamily M member 5 Proteins 0.000 description 1
- 241000406668 Loxodonta cyclotis Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 241000555745 Sciuridae Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 244000186561 Swietenia macrophylla Species 0.000 description 1
- 102100031215 Transient receptor potential cation channel subfamily M member 5 Human genes 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000012212 insulator Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000013160 medical therapy Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012543 microbiological analysis Methods 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001483 mobilizing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 101150103095 torA gene Proteins 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19713543A DE19713543B4 (de) | 1997-04-02 | 1997-04-02 | Bakterielle Plasmide |
PCT/EP1998/001720 WO1998044134A2 (de) | 1997-04-02 | 1998-04-01 | Bakterielle plasmide |
Publications (1)
Publication Number | Publication Date |
---|---|
UA73072C2 true UA73072C2 (en) | 2005-06-15 |
Family
ID=7825193
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UA99105881A UA73072C2 (en) | 1997-04-02 | 1998-01-04 | Plasmids of bacteria |
Country Status (32)
Country | Link |
---|---|
US (1) | US6391631B1 (cs) |
EP (1) | EP0975774B1 (cs) |
JP (2) | JP2000514661A (cs) |
KR (1) | KR100398558B1 (cs) |
CN (2) | CN1194093C (cs) |
AR (1) | AR010140A1 (cs) |
AT (1) | ATE277190T1 (cs) |
AU (1) | AU739941B2 (cs) |
BR (1) | BR9808458A (cs) |
CA (1) | CA2285633C (cs) |
CO (1) | CO4790114A1 (cs) |
CZ (2) | CZ294686B6 (cs) |
DE (2) | DE19713543B4 (cs) |
DK (1) | DK0975774T3 (cs) |
DZ (1) | DZ2454A1 (cs) |
EA (2) | EA003738B1 (cs) |
EE (1) | EE04944B1 (cs) |
ES (1) | ES2229492T3 (cs) |
HK (2) | HK1026233A1 (cs) |
HU (1) | HU228182B1 (cs) |
IL (2) | IL132101A0 (cs) |
NZ (1) | NZ338000A (cs) |
PE (1) | PE96799A1 (cs) |
PL (2) | PL192699B1 (cs) |
PT (1) | PT975774E (cs) |
SI (1) | SI0975774T1 (cs) |
SK (2) | SK284928B6 (cs) |
TR (1) | TR199902434T2 (cs) |
TW (1) | TW567225B (cs) |
UA (1) | UA73072C2 (cs) |
WO (1) | WO1998044134A2 (cs) |
ZA (1) | ZA982733B (cs) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19751242C2 (de) * | 1997-11-19 | 2001-02-08 | Pharma Zentrale Gmbh | DNA-Sequenzen aus Fimbriengenen von Escherichia coli Stamm DSM 6601 |
EP1038035A1 (de) * | 1997-11-19 | 2000-09-27 | Pharma-Zentrale Gmbh | VERFAHREN ZUR IDENTIFIZIERUNG VON $i(ESCHERICHIA COLI) STAMM DSM 6601 |
DE19915772C2 (de) * | 1998-11-18 | 2001-08-30 | Pharma Zentrale Gmbh | Verfahren zur Identifizierung von Escherichia coli Stamm DSM 6601 |
DE10155928A1 (de) * | 2001-11-15 | 2003-06-12 | Degussa | recA-negativer und rhaB-negativer Mikroorganismus |
US7648886B2 (en) * | 2003-01-14 | 2010-01-19 | Globalfoundries Inc. | Shallow trench isolation process |
DE10328669B4 (de) * | 2003-06-26 | 2005-12-01 | Pharma-Zentrale Gmbh | Plasmidfreier Klon des E. coli Stammes DSM 6601 |
CN100368549C (zh) * | 2006-03-29 | 2008-02-13 | 北京未名凯拓作物设计中心有限公司 | 一种细菌质粒及其衍生质粒与应用 |
EP2466678B1 (en) | 2009-08-10 | 2017-11-22 | LG Chem, Ltd. | Lithium secondary battery |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5843882A (en) * | 1995-04-27 | 1998-12-01 | The United States Of America As Represented By The Department Of Health And Human Services | Antiviral proteins and peptides |
CN1060807C (zh) * | 1995-05-25 | 2001-01-17 | 中国科学院微生物所 | 大肠杆菌中表达外源基因的质粒和牛凝乳酶原的生产方法 |
-
1997
- 1997-04-02 DE DE19713543A patent/DE19713543B4/de not_active Expired - Fee Related
-
1998
- 1998-01-04 UA UA99105881A patent/UA73072C2/uk unknown
- 1998-03-31 DZ DZ980064A patent/DZ2454A1/xx active
- 1998-04-01 SK SK1338-99A patent/SK284928B6/sk not_active IP Right Cessation
- 1998-04-01 CA CA002285633A patent/CA2285633C/en not_active Expired - Fee Related
- 1998-04-01 HU HU0001857A patent/HU228182B1/hu not_active IP Right Cessation
- 1998-04-01 CN CNB988044471A patent/CN1194093C/zh not_active Expired - Fee Related
- 1998-04-01 NZ NZ338000A patent/NZ338000A/en not_active IP Right Cessation
- 1998-04-01 CN CNB2005100059434A patent/CN100429313C/zh not_active Expired - Fee Related
- 1998-04-01 DK DK98919137T patent/DK0975774T3/da active
- 1998-04-01 DE DE59812000T patent/DE59812000D1/de not_active Expired - Lifetime
- 1998-04-01 SI SI9830713T patent/SI0975774T1/xx unknown
- 1998-04-01 SK SK44-2005A patent/SK284929B6/sk not_active IP Right Cessation
- 1998-04-01 PL PL373720A patent/PL192699B1/pl unknown
- 1998-04-01 WO PCT/EP1998/001720 patent/WO1998044134A2/de active IP Right Grant
- 1998-04-01 EP EP98919137A patent/EP0975774B1/de not_active Expired - Lifetime
- 1998-04-01 EA EA200000567A patent/EA003738B1/ru not_active IP Right Cessation
- 1998-04-01 PT PT98919137T patent/PT975774E/pt unknown
- 1998-04-01 PL PL336156A patent/PL192687B1/pl unknown
- 1998-04-01 CZ CZ19993482A patent/CZ294686B6/cs not_active IP Right Cessation
- 1998-04-01 TR TR1999/02434T patent/TR199902434T2/xx unknown
- 1998-04-01 EA EA199900893A patent/EA003700B1/ru not_active IP Right Cessation
- 1998-04-01 AU AU72095/98A patent/AU739941B2/en not_active Ceased
- 1998-04-01 IL IL13210198A patent/IL132101A0/xx active IP Right Grant
- 1998-04-01 CZ CZ2004894A patent/CZ294867B6/cs not_active IP Right Cessation
- 1998-04-01 KR KR10-1999-7009001A patent/KR100398558B1/ko not_active IP Right Cessation
- 1998-04-01 ES ES98919137T patent/ES2229492T3/es not_active Expired - Lifetime
- 1998-04-01 AT AT98919137T patent/ATE277190T1/de active
- 1998-04-01 BR BR9808458-5A patent/BR9808458A/pt not_active Application Discontinuation
- 1998-04-01 EE EEP199900445A patent/EE04944B1/xx unknown
- 1998-04-01 JP JP10541119A patent/JP2000514661A/ja active Pending
- 1998-04-01 ZA ZA982733A patent/ZA982733B/xx unknown
- 1998-04-02 PE PE1998000241A patent/PE96799A1/es not_active Application Discontinuation
- 1998-04-02 TW TW087105015A patent/TW567225B/zh not_active IP Right Cessation
- 1998-04-02 CO CO98018666A patent/CO4790114A1/es unknown
- 1998-04-02 AR ARP980101500A patent/AR010140A1/es active IP Right Grant
-
1999
- 1999-09-27 IL IL132101A patent/IL132101A/en not_active IP Right Cessation
-
2000
- 2000-09-01 HK HK00105484A patent/HK1026233A1/xx not_active IP Right Cessation
- 2000-10-02 US US09/676,974 patent/US6391631B1/en not_active Expired - Lifetime
-
2002
- 2002-05-02 JP JP2002130939A patent/JP2003000245A/ja active Pending
-
2006
- 2006-06-07 HK HK06106492.4A patent/HK1086596A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Dubnau et al. | Gene conservation in Bacillus species. I. Conserved genetic and nucleic acid base sequence homologies. | |
Cabanes et al. | Auto, a surface associated autolysin of Listeria monocytogenes required for entry into eukaryotic cells and virulence | |
Hartmann et al. | The glycosylated cell surface protein Rpf2, containing a resuscitation-promoting factor motif, is involved in intercellular communication of Corynebacterium glutamicum | |
JPH03504677A (ja) | リステリア検出のためのプローブ類及び方法 | |
UA73072C2 (en) | Plasmids of bacteria | |
Kleanthous et al. | Immunity proteins and their specificity for endonuclease colicins: telling right from wrong in protein–protein recognition | |
CN108103151A (zh) | 一种基于序列特异性核酸结合蛋白的核酸检测和分型的方法及其应用 | |
Vieira et al. | Agrobacterium tumefasciens-mediated transformation of the aquatic fungus Blastocladiella emersonii | |
Cossart | Actin-based bacterial motility: towards a definition of the minimal requirements | |
Pich et al. | Mycoplasma genitalium mg200 and mg386 genes are involved in gliding motility but not in cytadherence | |
US8101355B2 (en) | Method for cloning and expressing target gene by homologous recombination | |
ES2311700T3 (es) | La1 - el genoma de una cepa de lactobacillus. | |
Flores et al. | Gene transfer to cyanobacteria in the laboratory and in nature | |
US11767524B2 (en) | His-MBP tagged DNA endonuclease for facilitated enzyme removal | |
CN117264988A (zh) | AcrIIA27蛋白在调控Cas9基因编辑中的应用 | |
Amann et al. | Typing in situ with probes | |
CN100395328C (zh) | 大肠杆菌菌株dsm 6601的无质粒的克隆 | |
CN109553663A (zh) | 一种植物乳杆菌代谢fos的局部调控蛋白及其调控方法 | |
Sousa et al. | Antagonistic activity expressed by Shigella sonnei: identification of a putative new bacteriocin | |
Sakakibara et al. | How is the archaeal MCM helicase assembled at the origin? Possible mechanisms | |
CN109897092A (zh) | 一种蓝舌病病毒非结构蛋白ns3的可溶制备方法 | |
JPH0698800A (ja) | アコレプラズマの検出方法 | |
Sanschagrin et al. | Essential genes in the infection model of Pseudomonas aeruginosa PCR-based signature-tagged mutagenesis | |
Chatterjee et al. | Preparing nested-deletion template DNA for field inversion gel electrophoresis analyses and position-specific end sequencing with transposon primers | |
Tietze et al. | DNA probes for studying streptothricin resistance evolution in enteric bacteria |